What prostate cancer patient population would benefit from a brachytherapy boost after EBRT without the use of ADT?

Topics: Radiation Oncology • Genitourinary Cancers

Based on recent data published suggesting an OS advantage to the addition of ADT vs. brachytherapy boost to EBRT (Jackson et al, 2020), it is unclear what patients would be appropriate for EBRT+BT without ADT.

Answer from: Radiation Oncologist at Community Practice

The paper referenced in the question for better or worse is the best evidence we have regarding the benefit we can expect from a brachy boost, the benefit we can expect from the addition of ADT to EBRT, and if you were to compare EBRT+ADT vs EBRT+brachy. It shows that adding ADT has an OS benefit co...

Comments

Radiation Oncologist at Collom and Carney Clinic Assoc
"Brachytherapy monotherapy is underutilized"... H...

Radiation Oncologist at CoxHealth Radiation Oncology
This great study helps shed more light on this imp...

Radiation Oncologist at UCLA | VA Greater Los Angeles Healthcare System
@DrSpratticus sheds another meaningful light on a ...

Related Questions